or Try an Advanced Search...

    Peripheral Artery Disease Stocks List

    Symbol Grade Name % Change
    LMAT A LeMaitre Vascular, Inc. -0.71
    SWAV A ShockWave Medical, Inc. 0.00
    HUMA B Humacyte, Inc. 0.11
    View As Page of Charts
    Related Industries: Biotechnology Medical Devices Medical Instruments & Supplies
    Related Stock Lists: Artery Bypass Catheter Health Care Interventional Radiology Medicine Vascular Surgery Artery Disease Biotechnology Blood Clots Breakthrough Therapy Cardiology Cardiovascular System Chronic Condition Closure Systems Cordis Coronary Artery Disease Diabetes Dialysis Disease

    Related ETFs - A few ETFs which own one or more of the above listed Peripheral Artery Disease stocks.

    Symbol Grade Name Weight
    GRPM C Invesco S&P MidCap 400? GARP ETF 3.78
    TMFS A Motley Fool Small-Cap Growth ETF 3.78
    PINK D Simplify Health Care ETF 3.58
    CBSE A Changebridge Capital Sustainable Equity ETF 3.38
    XHE C SPDR S&P Health Care Equipment 3.22
    View all Peripheral Artery Disease ETFs...
    Compare ETFs
    Compare GRPM to TMFS Compare GRPM to XHE Compare TMFS to PINK

        Peripheral Artery Disease Stocks Recent News

        Date Stock Title
        May 8 LMAT Insider Sale: President and Director David Roberts Sells Shares of LeMaitre Vascular Inc (LMAT)
        May 7 SWAV Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y
        May 7 SWAV Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
        May 7 SWAV Beyond the Balance Sheet: What SWOT Reveals About Shockwave Medical Inc (SWAV)
        May 7 SWAV Shockwave Medical (SWAV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
        May 6 SWAV Shockwave Medical (SWAV) Q1 Earnings and Revenues Top Estimates
        May 6 SWAV Shockwave Medical Surpasses Analyst Revenue Forecasts in Q1 2024
        May 6 SWAV ShockWave Medical GAAP EPS of $1.44 beats by $0.47, revenue of $218.8M beats by $11.15M
        May 6 SWAV Shockwave Medical Reports First Quarter 2024 Financial Results
        May 6 SWAV Shockwave Medical (SWAV) Earnings Expected to Grow: What to Know Ahead of Q1 Release
        May 6 HUMA Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 10, 2024
        May 5 LMAT LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
        May 4 LMAT LeMaitre Vascular First Quarter 2024 Earnings: Beats Expectations
        May 3 SWAV ShockWave Medical Q1 2024 Earnings Preview
        May 3 LMAT LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2024 Earnings Call Transcript
        May 3 LMAT LeMaitre Vascular declares $0.16 dividend
        May 3 LMAT LeMaitre Vascular, Inc. (LMAT) Q1 2024 Earnings Call Transcript
        May 2 LMAT LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Top Estimates
        May 2 LMAT LeMaitre Vascular Inc (LMAT) Q1 2024 Earnings: Surpasses Analyst Revenue Forecasts
        May 2 LMAT LeMaitre Vascular GAAP EPS of $0.44 beats by $0.05, revenue of $53.5M beats by $2M
        Related Industries: Biotechnology Medical Devices Medical Instruments & Supplies
        Related Stock Lists: Artery Bypass Catheter Health Care Interventional Radiology Medicine Vascular Surgery Artery Disease Biotechnology Blood Clots Breakthrough Therapy Cardiology Cardiovascular System Chronic Condition Closure Systems Cordis Coronary Artery Disease Diabetes Dialysis Disease
        Peripheral Artery Disease

        Peripheral Artery Disease (PAD) is a condition in which the arteries that supply blood to the legs and feet become narrowed or blocked due to a buildup of plaque. This can cause pain, numbness, and other symptoms in the legs and feet. PAD can also increase the risk of heart attack, stroke, and other serious health problems. Treatment for PAD may include lifestyle changes, medications, and surgery.

        Browse All Tags